1-2 of 2
Ana Fernandez-Cruz, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Infection Risk in Lymphoproliferative Diseases (LPD) Treated with Targeted Drugs. Geltamo Real-Life Experience

Maria Stefania Infante, MD, Ana Fernandez-Cruz, MD, Lucia Nuñez, Cecilia Carpio, MD, Ana Jimenez-Ubieto, Javier Lopez Jimenez, MD PhD, Lourdes Vázquez, MD, Raquel Del Campo, Samuel Romero, MD, Carmen Alonso Prieto, Daniel Murillo, Margarita Prat, Jose Luis Plana Cuenca, Paola Villaverde Gutiérrez, Gabriela Bastidas, MD, Ana Bocanegra, Ángel Serna, MD, Rodrigo de Nicolas, Juan Marquet Palomanes, Julio Garcia-Suarez, Maria Carmen Mas Ochoa, Alessandra Comai, MD, Xabier Martin, Cristina Seri, MD, Belen Navarro Matilla, Jose Angel Hernandez-Rivas, MD PhD, Armando Lopez-Guillermo, Isabel Ruiz-Campos, Carlos Grande
Journal: Blood
Blood (2020) 136 (Supplement 1): 37–40.
https://doi.org/10.1182/blood-2020-134729
Published: 2020
Journal Articles

Weekly Screening for Multidrug-Resistant Organisms Identifies High Number of Colonizations in Patients Undergoing Stem Cell Transplantation

Silvia Monsalvo, Pascual Balsalobre, PhD, Nieves Dorado Herrero, MD, Laura Solán, PhD, Ana Fernandez-Cruz, MD, Marina Machado, MD, Maria Dolores Vigil-Escribano, MD, Javier Anguita, MD PhD, Jose Luis Díez-Martín, MD PhD, Mi Kwon
Journal: Blood
Blood (2018) 132 (Supplement 1): 5703.
https://doi.org/10.1182/blood-2018-99-118713
Published: 2018